A RANDOMIZED CONTROLLED TRIAL OF ROPIVACAINE INJECTION AFTER ROBOTIC THYROIDECTOMY

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001085

Enrollment

108

Registered

2014-04-22

Start date

2012-06-11

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Ropivacaine 100mg in 40ml normal sailne infiltration flap site before wound closure in robotic thyroidecotmy through trochar site.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Plan to robotic thyroidectomy 2. Patients agreed to this study with sign a consent form

Exclusion criteria

Exclusion criteria: 1. Amide- local anaesthetic hypersensitivity patients. 2. Users with Anti coagulation including aspirin and anti- platelet agents 3. Pregnats wemans 4. Uncontrolled hypertension or diabetus patients. 5. Severe coagulopathy, cardiopulmanary disease, chronic renal failure patients. 6. Stroke history patients.

Design outcomes

Primary

Measure	Time frame
post operative pain score	—

Secondary

Measure	Time frame
analgesic requirements ;Postoperative adverse effect	—

Countries

Korea, Republic of

Contacts

Public ContactDong Sik Bae

Inje University Haeundae Paik Hospital

Outcome results